WTO Delays Decision On Proposal To Waive Intellectual Property Rules For COVID-19 Drugs, Vaccines

Reuters: WTO delays decision on waiver on COVID-19 drug, vaccine rights
“World Trade Organization members on Thursday delayed a decision on a proposal to waive intellectual property rules for COVID-19 drugs and vaccines amid ongoing opposition from wealthy countries, a Geneva trade official said. ‘Big Pharma’ has rejected an idea proposed by India and South Africa that would grant compulsory licensing of the vaccines and drugs by overriding patent rules of WTO’s Trade-Related Aspects of Intellectual Property (TRIPS) agreement, allowing generic or other manufactures to make the new products. The proposal has won support from some countries at the WTO but is opposed by Western countries, including Britain, Switzerland, and the United States, which have strong domestic pharmaceutical industries…” (Farge/Nebehay, 12/10).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.